Mehnert, J. M., Panda, A., Zhong, H., Hirshfield, K., Damare, S., Lane, K., . . . Ganesan, S. (2016). Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer. J Clin Invest.
Dyfyniad Arddull ChicagoMehnert, Janice M., et al. "Immune Activation and Response to Pembrolizumab in POLE-mutant Endometrial Cancer." J Clin Invest 2016.
Dyfyniad MLAMehnert, Janice M., et al. "Immune Activation and Response to Pembrolizumab in POLE-mutant Endometrial Cancer." J Clin Invest 2016.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.